Fas ligand (FasL) is a member of the tumor necrosis factor family. FasL induces apoptosis after binding its receptor and forming the death-inducing signaling complex (DISC). Once bound the complex regulates the immune system in several ways such as T-cell homeostasis, cytotoxic T-cell activity, maternal tolerance to fetus, and tumor counterattack.
Swiss-Prot Accession Number: P48023
A leading global drug discovery and development laboratory, IQVIA Laboratories (the laboratory business of IQVIA) provides customers with a comprehensive assemblage of solutions encompassing central laboratory and specialty biomarker services including genomics, immunoassays, flow cytometry, anatomic pathology, precision medicine assays, vaccine assays, ADME and bioanalytical along with extensive offerings in antibody drug discovery, biomarker discovery, and decentralized clinical trial lab solutions.
Learn more at labs.iqvia.com
Copyright 2025 Rules-Based Medicine. All rights reserved. RBM does not sell your personal information.